Researchers at the Luxembourg Institute of Health are investigating a new approach to helping people who are allergic to cat dander, specifically, the major cat allergen Fel d 1.
Allergen-specific immunotherapy aims to provide long-term relief from allergies, but much remains to be learned about the therapy.
In a study published in December 2020 in the journal Allergy, researchers gave mice higher doses of a known immunomodulatory adjuvant called CpG than have been used in the past and also used a different administration route — subcutaneous injection, or under the skin.
All major hallmarks of allergy were reverted, leading the study authors to recommend further investigation of this promising treatment.
This article was originally published by Pcdn.co. Read the original article here.